Lanzul

Lansoprazole, the active ingredient in Lanzul, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and H. pylori infection in adults. GNH USA supplies Lanzul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the acid‑secreting pathway of the stomach and is indicated for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and reduces recurrence risk. - Erosive esophagitis: promotes mucosal healing and decreases acid exposure. - Helicobacter pylori eradication: used as part of combination therapy to eradicate the bacterium.

Adverse reactions may occur with lansoprazole therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Clostridioides difficile infection: severe colitis with diarrhea. - Liver enzyme elevation: signs of hepatic dysfunction. - Hypomagnesemia: low magnesium levels with long‑term use. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Pancreatitis: inflammation of the pancreas.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: long‑term treatment may cause deficiency. - Use cautiously in the elderly: higher risk of fractures and infections. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at room temperature: keep in the original pack, protect from moisture.

Lansoprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - Methotrexate: increased toxicity, especially at high doses.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: elevated serum concentrations, watch for toxicity. - Diazepam: increased plasma levels, may require dose adjustment.